AIM
ARK Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.62M | Sell |
12,606
-1,088
| -8% | -$571K | 0.05% | 103 |
|
|
2025
Q1 | $8.69M | Buy |
13,694
+502
| +4% | +$318K | 0.09% | 97 |
|
|
2024
Q4 | $9.4M | Sell |
13,192
-1,959
| -13% | -$1.4M | 0.08% | 99 |
|
|
2024
Q3 | $15.9M | Sell |
15,151
-714
| -5% | -$751K | 0.15% | 72 |
|
|
2024
Q2 | $16.7M | Sell |
15,865
-2,348
| -13% | -$2.47M | 0.15% | 74 |
|
|
2024
Q1 | $17.5M | Sell |
18,213
-9,518
| -34% | -$9.16M | 0.12% | 86 |
|
|
2023
Q4 | $24.4M | Sell |
27,731
-9
| -0% | -$7.9K | 0.14% | 71 |
|
|
2023
Q3 | $22.8M | Sell |
27,740
-4,513
| -14% | -$3.71M | 0.17% | 69 |
|
|
2023
Q2 | $23.2M | Sell |
32,253
-1,338
| -4% | -$961K | 0.15% | 77 |
|
|
2023
Q1 | $27.6M | Sell |
33,591
-462
| -1% | -$380K | 0.19% | 55 |
|
|
2022
Q4 | $24.6M | Sell |
34,053
-2,888
| -8% | -$2.08M | 0.21% | 61 |
|
|
2022
Q3 | $25.4M | Sell |
36,941
-18,870
| -34% | -$13M | 0.18% | 72 |
|
|
2022
Q2 | $37.1M | Sell |
55,811
-1,962
| -3% | -$1.3M | 0.22% | 67 |
|
|
2022
Q1 | $40.4M | Sell |
57,773
-15,220
| -21% | -$10.6M | 0.17% | 76 |
|
|
2021
Q4 | $46.1M | Sell |
72,993
-355,154
| -83% | -$224M | 0.14% | 95 |
|
|
2021
Q3 | $259M | Sell |
428,147
-284,901
| -40% | -$172M | 0.62% | 40 |
|
|
2021
Q2 | $398M | Sell |
713,048
-505,922
| -42% | -$283M | 0.74% | 36 |
|
|
2021
Q1 | $577M | Buy |
1,218,970
+767,152
| +170% | +$363M | 1.15% | 25 |
|
|
2020
Q4 | $218M | Buy |
+451,818
| New | +$218M | 0.58% | 48 |
|
|
2020
Q2 | – | Sell |
-89
| Closed | -$43K | – | 215 |
|
|
2020
Q1 | $43K | Hold |
89
| – | – | ﹤0.01% | 186 |
|
|
2019
Q4 | $33K | Sell |
89
-39,984
| -100% | -$14.8M | ﹤0.01% | 217 |
|
|
2019
Q3 | $11.1M | Buy |
40,073
+11,480
| +40% | +$3.18M | 0.24% | 56 |
|
|
2019
Q2 | $8.95M | Buy |
28,593
+15,356
| +116% | +$4.81M | 0.23% | 57 |
|
|
2019
Q1 | $5.44M | Sell |
13,237
-684
| -5% | -$281K | 0.16% | 66 |
|
|
2018
Q4 | $5.2M | Sell |
13,921
-9,319
| -40% | -$3.48M | 0.21% | 60 |
|
|
2018
Q3 | $9.39M | Buy |
23,240
+4,658
| +25% | +$1.88M | 0.28% | 58 |
|
|
2018
Q2 | $6.41M | Buy |
18,582
+15,257
| +459% | +$5.26M | 0.23% | 61 |
|
|
2018
Q1 | $1.15M | Buy |
3,325
+564
| +20% | +$194K | 0.06% | 99 |
|
|
2017
Q4 | $1.04M | Buy |
2,761
+530
| +24% | +$199K | 0.08% | 97 |
|
|
2017
Q3 | $998K | Buy |
2,231
+997
| +81% | +$446K | 0.12% | 86 |
|
|
2017
Q2 | $606K | Buy |
1,234
+544
| +79% | +$267K | 0.12% | 77 |
|
|
2017
Q1 | $267K | Buy |
690
+68
| +11% | +$26.3K | 0.08% | 79 |
|
|
2016
Q4 | $228K | Buy |
+622
| New | +$228K | 0.08% | 74 |
|